Securities Law

At SLAS 2026, MGI Tech unveiled intelligent platforms for proteomics and clinical automation, signaling a major push to accelerate scientific discovery.

Celebrating a half-century of progress, Liberty Hill Foundation's anniversary gala was an urgent plea to fund the fight for Los Angeles's future.

Strong glaucoma sales and disciplined spending helped Iridex narrow its quarterly loss, signaling resilience despite retina segment woes and global headwinds.

After a record stock plunge, Planet Fitness is under investigation for misleading investors with rosy forecasts that masked serious operational headwinds.

Smart Props Solution launches a blockchain platform offering fractional real estate ownership for as little as $100, but navigating this new frontier has risks.

As summer begins, the CAA urges Canadians to plan safe rides, citing new data on the underestimated dangers of cannabis-impaired driving on our roads.

Trusted Advisor Search, led by a 40-year industry veteran, launches with a new model embedding legal counsel to protect advisors from career-move pitfalls.

Singapore's TechCreate reports 54% revenue growth and a quantum tech leap, but a regulatory trading halt has left investors and the market in the dark.

A federal judge has denied Binance and its ex-CEO's attempt to force arbitration, allowing a billion-dollar securities class action to proceed in court.

FDA approves the first generic of a vital nutrition drug, granting Apotex a 180-day exclusive edge and signaling major cost savings for healthcare.

Facing a shareholder revolt after a damning indictment, Supermicro launches a major probe into a $2.5B shadow trade scheme. Is it too little, too late?

With new clinical trial data showing its AI is superior for complex AFib, Volta Medical heads to a major conference to change the standard of care.

The new algorithm aims to systematically filter out harmful interactions and reduce hidden trading costs in the complex world of off-exchange trading.

Willow Lane's merger with AI cloud provider Boost Run is on hold pending SEC approval, highlighting regulatory hurdles in the high-stakes GPU compute race.

American Ventures publicizes support from 85+ investors, a move to counter a recent fraud lawsuit and an ongoing SEC investigation into its practices.

An ETF offers retail investors a ticket to SpaceX's massive IPO, but a bitter public dispute with critics raises questions about transparency and risk.

OTC-listed APPlife Digital Solutions is launching weekly investor calls, a bold move to build trust. But can it overcome its financial hurdles?

With the FDA mandating a move from animal testing, BioIVT is positioning itself at the center of the NAMs revolution with key industry events and research.

As AI and tech lawsuits surge, a specialized list of legal experts emerges to handle complex disputes beyond the courtroom. Here's why it matters.

As spring car shopping begins, buyers face a surge in sophisticated fraud. Learn how to spot odometer rollbacks, VIN cloning, and other hidden traps.